Daewoong Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	168,942	102,950	111,506	102,951	75,907
Short-Term Investments	3,860	5,077	3,000	10,000	97,827
Trading Asset Securities	-	8,320	23,179	27,700	-
Cash & Short-Term Investments	172,801	116,347	137,685	140,651	173,734
Cash Growth	48.52%	-15.50%	-2.11%	-19.04%	-1.91%
Accounts Receivable	166,724	160,742	137,506	142,165	121,591
Other Receivables	48,336	51,150	40,386	36,979	36,916
Receivables	215,161	211,894	177,892	179,144	159,508
Inventory	310,876	256,353	241,545	208,736	170,559
Prepaid Expenses	17,896	15,950	8,534	7,598	6,604
Other Current Assets	15,624	12,248	9,168	12,840	9,996
Total Current Assets	732,358	612,792	574,824	548,968	520,401
Property, Plant & Equipment	842,341	675,666	521,919	440,890	395,866
Long-Term Investments	250,179	180,703	203,792	146,335	118,369
Goodwill	60,848	60,848	60,848	60,848	60,848
Other Intangible Assets	78,106	83,069	80,001	84,620	81,406
Long-Term Accounts Receivable	-	-	-	-	569.7
Long-Term Deferred Tax Assets	78,580	68,786	71,304	64,136	58,565
Long-Term Deferred Charges	228,570	202,793	156,636	120,540	82,915
Other Long-Term Assets	88,475	88,613	97,660	93,745	91,747
Total Assets	2,362,799	1,976,977	1,770,311	1,563,341	1,410,687
Accounts Payable	106,234	83,043	101,099	83,401	70,852
Accrued Expenses	24,963	24,010	24,085	20,635	15,485
Short-Term Debt	70,829	206,495	167,426	141,742	56,109
Current Portion of Long-Term Debt	205,947	115,000	204,943	91,931	199,878
Current Portion of Leases	1,171	2,002	1,961	1,183	987.32
Current Income Taxes Payable	11,545	8,146	14,497	4,906	4,734
Current Unearned Revenue	14.84	76.15	59.22	30.67	-
Other Current Liabilities	168,120	155,573	153,047	129,004	112,615
Total Current Liabilities	588,823	594,346	667,117	472,831	460,660
Long-Term Debt	550,561	324,478	65,000	204,840	181,713
Long-Term Leases	882.62	1,274	1,941	7,015	7,008
Pension & Post-Retirement Benefits	-	722.46	-	-	-
Long-Term Deferred Tax Liabilities	1,615	3,530	5,009	4,053	3,580
Other Long-Term Liabilities	86,262	90,573	90,547	133,378	59,811
Total Liabilities	1,228,144	1,014,923	829,614	822,118	712,772
Common Stock	28,966	28,966	28,966	28,966	28,966
Additional Paid-In Capital	149,816	149,892	149,175	121,582	123,649
Retained Earnings	833,595	635,674	618,864	504,294	467,361
Treasury Stock	-2,850	-2,850	-2,850	-18,360	-18,360
Comprehensive Income & Other	-3,435	-17,044	-26,852	-28,466	-32,085
Total Common Equity	1,006,093	794,640	767,303	608,017	569,531
Minority Interest	128,562	132,345	144,978	133,206	128,384
Shareholders' Equity	1,134,656	962,055	940,696	741,223	697,915
Total Liabilities & Equity	2,362,799	1,976,977	1,770,311	1,563,341	1,410,687
Total Debt	829,390	649,249	441,270	446,711	445,695
Net Cash (Debt)	-656,589	-532,902	-303,585	-306,060	-271,961
Net Cash Per Share	-57063.54	-46314.03	-26572.35	-27649.69	-24713.54
Filing Date Shares Outstanding	11.51	11.51	11.51	11.07	11.07
Total Common Shares Outstanding	11.51	11.51	11.51	11.07	11.07
Working Capital	143,535	18,447	-92,293	76,137	59,742
Book Value Per Share	87438.70	69061.46	66685.66	54928.72	51451.87
Tangible Book Value	867,140	650,723	626,454	462,550	427,278
Tangible Book Value Per Share	75362.36	56553.74	54444.60	41787.05	38600.56
Land	89,212	83,840	97,598	94,459	69,482
Buildings	316,093	296,280	267,669	261,085	247,556
Machinery	379,247	360,301	340,864	325,145	307,618
Construction In Progress	400,304	267,131	131,731	58,328	47,216

Source: S&P Global Market Intelligence. Standard template. Financial Sources.